Houston-based biopharmaceutical company Marker Therapeutics, Inc., with a market capitalization of $20.45 million, reported a change in its board composition earlier this week. On Thursday, the firm ...

Amentum Holdings, Inc. (NYSE:AMTM), a Delaware-incorporated business services provider with an $8.39 billion revenue base and $4.75 billion market capitalization, has announced the approval of a ...